Log in to save to my catalogue

A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for interm...

A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for interm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0da6d6b2090e43edb417b2d64acacd2f

A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high risk pulmonary embolism-the STRATIFY trial: design and statistical analysis plan

About this item

Full title

A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high risk pulmonary embolism-the STRATIFY trial: design and statistical analysis plan

Publisher

England: BioMed Central Ltd

Journal title

Current controlled trials in cardiovascular medicine, 2024-12, Vol.25 (1), p.853-12, Article 853

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Intermediate-high risk pulmonary embolism (PE) carries a significant risk of hemodynamic deterioration or death. Treatment should balance efficacy in reducing clot burden with the risk of complications, particularly bleeding. Previous studies on high-dose, short-term thrombolysis with alteplase (rtPA) showed a reduced risk of hemodynamic deteriorat...

Alternative Titles

Full title

A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high risk pulmonary embolism-the STRATIFY trial: design and statistical analysis plan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0da6d6b2090e43edb417b2d64acacd2f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0da6d6b2090e43edb417b2d64acacd2f

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-024-08688-4

How to access this item